5 assets in Inherited Disease Susceptibility

Therapeutic assets addressing Inherited Disease Susceptibility, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cephalexin Inherited Disease Susceptibility	University of California, San Francisco	P2	CCC (53)
Aln-Pnp Inherited Disease Susceptibility	Regeneron Pharmaceuticals	P1	CC (47)
Minoxidil Inherited Disease Susceptibility	Duke University	P1	CC (43)
Fluconazole Inherited Disease Susceptibility	Bochud Pierre-Yves	N/A	D (30)
Posaconazole Inherited Disease Susceptibility	Bochud Pierre-Yves	N/A	D (30)